IS5410A - Ný mótlyf taugapeptíðs Y (NPY) - Google Patents

Ný mótlyf taugapeptíðs Y (NPY)

Info

Publication number: IS5410A
Authority: IS; Iceland
Prior art keywords: npy; antagonist; new neuronal; neuronal peptide; peptide
Prior art date: 1997-09-23

Application number

IS5410A

Other languages

English (en)

Inventor

Bergman Nils-Åke

D'ambra Thomas

Pilling Garry

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-23

Filing date

2000-03-20

Publication date

2000-03-20

2000-03-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2000-03-20 Publication of IS5410A publication Critical patent/IS5410A/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Neurosurgery (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)

IS5410A 1997-09-23 2000-03-20 Ný mótlyf taugapeptíðs Y (NPY) IS5410A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9703414A SE9703414D0 (sv)	1997-09-23	1997-09-23	New compounds
PCT/SE1998/001686 WO1999015498A1 (en)	1997-09-23	1998-09-21	New npy antagonists

Publications (1)

Publication Number	Publication Date
IS5410A true IS5410A (is)	2000-03-20

Family

ID=20408331

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5410A IS5410A (is)	1997-09-23	2000-03-20	Ný mótlyf taugapeptíðs Y (NPY)

Country Status (21)

Country	Link
US (1)	US6127414A (is)
EP (1)	EP1017672B1 (is)
JP (1)	JP2001517651A (is)
KR (1)	KR20010024220A (is)
CN (1)	CN1279666A (is)
AR (1)	AR017138A1 (is)
AT (1)	ATE228500T1 (is)
AU (1)	AU9288998A (is)
BR (1)	BR9812492A (is)
CA (1)	CA2303528A1 (is)
DE (1)	DE69809782T2 (is)
EE (1)	EE200000171A (is)
IL (1)	IL134993A0 (is)
IS (1)	IS5410A (is)
NO (1)	NO20001483L (is)
PL (1)	PL339617A1 (is)
SE (1)	SE9703414D0 (is)
SK (1)	SK3602000A3 (is)
TR (1)	TR200000785T2 (is)
WO (1)	WO1999015498A1 (is)
ZA (1)	ZA988353B (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9802075D0 (sv) *	1998-06-11	1998-06-11	Astra Ab	New use
US6312898B1 (en) *	1999-04-15	2001-11-06	Hormos Medical Oy, Ltd.	Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene
SE9902596D0 (sv) *	1999-07-06	1999-07-06	Astra Ab	Pharmaceutically active compounds
EP1095933A1 (en)	1999-10-30	2001-05-02	Aventis Pharma Deutschland GmbH	Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
SE0101328D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	Therapeutic treatment
JP4010951B2 (ja) *	2001-05-15	2007-11-21	大正製薬株式会社	アルギニン誘導体
ATE462432T1 (de)	2003-05-05	2010-04-15	Probiodrug Ag	Glutaminylcyclase-hemmer
JP2007509898A (ja)	2003-11-03	2007-04-19	プロビオドルグエージー	神経障害治療に有用な組合せ
FR2864830B1 (fr) *	2004-01-06	2006-03-10	Centre Nat Rech Scient	Procede de synthese sur support solide de composes peptidiques, notamment de composes peptidiques comportant un residu arginine
KR101099206B1 (ko)	2004-02-05	2011-12-27	프로비오드룩 아게	신규한 글루타미닐 시클라제 저해제
FR2884516B1 (fr) *	2005-04-15	2007-06-22	Cerep Sa	Antagonistes npy, preparation et utilisations
KR100689499B1 (ko) *	2005-10-26	2007-03-02	삼성전자주식회사	휴대단말기에서 키 설정 정보 디스플레이 방법
WO2007064272A1 (en) *	2005-11-29	2007-06-07	Astrazeneca Ab	Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists
JP5379692B2 (ja)	2006-11-09	2013-12-25	プロビオドルグエージー	潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
EP2091948B1 (en)	2006-11-30	2012-04-18	Probiodrug AG	Novel inhibitors of glutaminyl cyclase
CA2679446C (en)	2007-03-01	2016-05-17	Probiodrug Ag	New use of glutaminyl cyclase inhibitors
US9656991B2 (en)	2007-04-18	2017-05-23	Probiodrug Ag	Inhibitors of glutaminyl cyclase
BR112012008346B1 (pt)	2009-09-11	2021-12-21	Vivoryon Therapeutics N.V.	Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
WO2011107530A2 (en)	2010-03-03	2011-09-09	Probiodrug Ag	Novel inhibitors
DK2545047T3 (da)	2010-03-10	2014-07-28	Probiodrug Ag	Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
EP2560953B1 (en)	2010-04-21	2016-01-06	Probiodrug AG	Inhibitors of glutaminyl cyclase
WO2012123563A1 (en)	2011-03-16	2012-09-20	Probiodrug Ag	Benz imidazole derivatives as inhibitors of glutaminyl cyclase
PL3461819T3 (pl)	2017-09-29	2020-11-30	Probiodrug Ag	Inhibitory cyklazy glutaminylowej
JP2025540658A (ja) *	2022-11-23	2025-12-16	ラディオネティクスオンコロジー，インク．	神経ペプチドｙ１受容体（ｎｐｙ１ｒ）を標的とした治療薬およびその使用
TW202535356A (zh) *	2023-12-28	2025-09-16	美商萊迪奧尼提斯腫瘤醫學公司	神經肽y1受體(npy1r)靶向治療劑及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5873821A (en) *	1992-05-18	1999-02-23	Non-Invasive Technology, Inc.	Lateralization spectrophotometer
DE4326465A1 (de) *	1993-01-20	1995-02-09	Thomae Gmbh Dr K	Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19544687A1 (de) *	1995-11-30	1997-06-05	Thomae Gmbh Dr K	Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19544686A1 (de) *	1995-11-30	1997-06-05	Thomae Gmbh Dr K	Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
CA2242579A1 (en) *	1996-01-09	1997-07-17	Eli Lilly And Company	Benzimidzolyl neuropeptide y receptor antagonists
US6011039A (en) *	1996-03-21	2000-01-04	Banyu Pharmaceutical Co., Ltd.	Aminopyridine derivatives
EP1007073A4 (en) *	1996-06-04	2002-03-27	Synaptic Pharma Corp	METHODS OF MODIFYING FOOD BEHAVIOR, COMPOUNDS USEFUL IN SAID METHODS, AND DNA ENCODING A HYPOTHALAMIC NEUROPEPTIDE Y / PEPTIDE YY Y5 RECEPTOR
ATE230403T1 (de) *	1996-07-23	2003-01-15	Neurogen Corp	Einige amido- und ammo- substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifische ligande
CA2260982A1 (en) *	1996-07-23	1998-01-29	Neurogen Corporation	Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
DE69721541T2 (de) *	1996-07-23	2004-03-18	Neurogen Corp., Branford	Einige amido-und amino-substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifischen liganden
EP0984778B1 (en) *	1996-08-23	2002-06-12	Agouron Pharmaceuticals, Inc.	Neuropeptide-y ligands
AU5135998A (en) *	1996-12-03	1998-06-29	Banyu Pharmaceutical Co., Ltd.	Novel urea derivatives
WO1998025907A1 (en) *	1996-12-12	1998-06-18	Banyu Pharmaceutical Co., Ltd.	Pyrazole derivatives
CA2274593A1 (en) *	1996-12-13	1998-06-18	Banyu Pharmaceutical Co., Ltd.	Novel aminopyrazole derivatives
CA2274594C (en) *	1996-12-16	2006-10-10	Banyu Pharmaceutical Co., Ltd.	Aminopyrazole derivatives
JP2002514199A (ja) *	1997-02-04	2002-05-14	ブリストル−マイヤーズスクイブカンパニー	Ｎｐｙ拮抗剤としてのジヒドロピリミドン誘導体
CA2251580A1 (en) *	1997-02-14	1998-08-20	Bayer Corporation	Amides as npy5 receptor antagonists
JP2002241368A (ja) *	1997-02-18	2002-08-28	Shionogi & Co Ltd	新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
AU6309698A (en) *	1997-03-12	1998-09-29	Banyu Pharmaceutical Co., Ltd.	Drugs containing aminopyridine derivatives as the active ingredient
US5889016A (en) *	1997-06-26	1999-03-30	Bristol-Myers Squibb Company	Dihydropyrimidone derivatives as NPY antagonists

1997
- 1997-09-23 SE SE9703414A patent/SE9703414D0/xx unknown
1998
- 1998-09-11 ZA ZA988353A patent/ZA988353B/xx unknown
- 1998-09-21 PL PL98339617A patent/PL339617A1/xx unknown
- 1998-09-21 US US09/171,779 patent/US6127414A/en not_active Expired - Fee Related
- 1998-09-21 WO PCT/SE1998/001686 patent/WO1999015498A1/en not_active Ceased
- 1998-09-21 CN CN98811336A patent/CN1279666A/zh active Pending
- 1998-09-21 AT AT98945708T patent/ATE228500T1/de not_active IP Right Cessation
- 1998-09-21 JP JP2000512808A patent/JP2001517651A/ja active Pending
- 1998-09-21 SK SK360-2000A patent/SK3602000A3/sk unknown
- 1998-09-21 EP EP98945708A patent/EP1017672B1/en not_active Expired - Lifetime
- 1998-09-21 CA CA002303528A patent/CA2303528A1/en not_active Abandoned
- 1998-09-21 KR KR1020007003029A patent/KR20010024220A/ko not_active Withdrawn
- 1998-09-21 AU AU92889/98A patent/AU9288998A/en not_active Abandoned
- 1998-09-21 IL IL13499398A patent/IL134993A0/xx unknown
- 1998-09-21 EE EEP200000171A patent/EE200000171A/xx unknown
- 1998-09-21 BR BR9812492-7A patent/BR9812492A/pt not_active IP Right Cessation
- 1998-09-21 TR TR2000/00785T patent/TR200000785T2/xx unknown
- 1998-09-21 DE DE69809782T patent/DE69809782T2/de not_active Expired - Fee Related
- 1998-09-22 AR ARP980104740A patent/AR017138A1/es unknown
2000
- 2000-03-20 IS IS5410A patent/IS5410A/is unknown
- 2000-03-22 NO NO20001483A patent/NO20001483L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1279666A (zh)	2001-01-10
IL134993A0 (en)	2001-05-20
CA2303528A1 (en)	1999-04-01
ATE228500T1 (de)	2002-12-15
BR9812492A (pt)	2000-09-26
EP1017672A1 (en)	2000-07-12
NO20001483D0 (no)	2000-03-22
EP1017672B1 (en)	2002-11-27
AR017138A1 (es)	2001-08-22
DE69809782T2 (de)	2003-07-17
SK3602000A3 (en)	2001-01-18
SE9703414D0 (sv)	1997-09-23
US6127414A (en)	2000-10-03
KR20010024220A (ko)	2001-03-26
ZA988353B (en)	1999-03-23
NO20001483L (no)	2000-05-23
JP2001517651A (ja)	2001-10-09
WO1999015498A1 (en)	1999-04-01
EE200000171A (et)	2001-04-16
TR200000785T2 (tr)	2000-09-21
PL339617A1 (en)	2001-01-02
DE69809782D1 (de)	2003-01-09
AU9288998A (en)	1999-04-12

Publication	Publication Date	Title
IS5410A (is)	2000-03-20	Ný mótlyf taugapeptíðs Y (NPY)
NO2010013I2 (no)	2015-05-18	Rekombinant FSH-CTP
EP0986385A4 (en)	2001-05-16	GONADORELIN ANTAGONISTS
ID24289A (id)	2000-07-13	Benzotiazol inhibitor-inhibitor protein terosin kinase
DE69833228D1 (de)	2006-04-06	Brückenzünder
DK1042359T3 (da)	2005-11-28	k-Opioidreceptorpeptider
ATE277050T1 (de)	2004-10-15	Trizyclische vasopressin agoniste
DK0894831T3 (da)	2003-01-27	Quinoxalin-monoazo-acetarylid-pigment
NO994548D0 (no)	1999-09-20	Rekkverk
DE69811119D1 (de)	2003-03-06	Konferenzeinrichtung
DK0862850T3 (da)	2003-08-25	Mejetærsker
NO974175L (no)	1999-03-11	B°lgekraftverk
DE69809903D1 (de)	2003-01-16	Erhöhter bodenbelag
FI973782A0 (fi)	1997-09-25	Linjefrekvenseffektkonverter fraon vaexelstroem till vaexelstroem
KR980000237U (ko)	1998-03-30	넥타이
FI973099A0 (fi)	1997-07-24	Installationsanordning hos balkongglasering
ATA65497A (de)	2001-11-15	Bauelement
KR970702876A (ko)	1997-06-10	뉴로키닌 길항제(Neurokinine (tachykinine) antagonists)
KR970053212U (ko)	1997-10-13	넥타이
ITMI972543A1 (it)	1999-05-15	Proteina p27bbp
DK1017798T3 (da)	2005-09-05	Lunasinpeptider
NO20000976D0 (no)	2000-02-25	Peptider
FIU970432U0 (fi)	1997-10-07	Housuvaippa
FI974114A0 (fi)	1997-11-03	Skorstenshatt (regntak)
NO975448L (no)	1999-05-27	L°fteverkt°y